Saku App
Saku Terminal • $ABBVLive $ABBV AI Target, Catalysts & Support Levels
OPEN
Saku Logo
Saku
Back to Saku Market Terminal
Climate: BULLISH FLOW
Updated Nov 22, 2026
Saku AI Market Briefing • $ABBV (AbbVie Inc.)

$ABBV (AbbVie Inc.) Support & Resistance Levels, AI Price Target & Institutional Flow.

Today, $ABBV (AbbVie Inc.) trades at $286.20 (+0.94%) with a 64/100 Momentum Pulse (BULLISH FLOW) and 14D RSI at 46.7 (NEUTRAL CONSOLIDATION (46.7)). Unlock the live $ABBV support and resistance levels, 30D Put Wall floor, 20D SMA pivot, Call Wall ceiling, dark pool flow, and locked 1-Month AI Price Target (+14.2% upside corridor) below—or create a free 24/7 AI quant agent to guard $ABBV.

Saku AI Synthesis • Why Is $ABBV Moving?
30D Support$272.70
30D Resistance$295.03
20-Day SMA$290.44
14-Day RSI46.7

Spot Price: $286.20 | 30-Day Support Floor: $272.70 (4.72% above) | 10-Day EMA: $290.00 | 20-Day SMA Pivot: $290.44 | 30-Day Resistance Ceiling: $295.03 (3.09% below) | 14-Day RSI: 46.7 (NEUTRAL CONSOLIDATION (46.7)) | 30-Day Trading Corridor: 8.19% span. Value and mean-reversion buyers in AbbVie Inc. ($ABBV) are monitoring the $272.70 30-day mechanical support floor (spot price at $286.20 sits 4.72% above support with 14-day RSI at 46.7 (NEUTRAL CONSOLIDATION (46.7))). Reclaiming the 10-day EMA ($290.00) and 20-day SMA pivot ($290.44) is the primary technical trigger to ignite a move back toward the $295.03 resistance ceiling.

LIVE TERMINAL TELEMETRY
$286.20+0.94%
BULLISH FLOW
$ABBV 30-DAY PRICE ACTION • BULLISH FLOWUpdated Nov 22, 2026
$ABBV Momentum Pulse (1–100)64/100
Fundamental Health Score74/100
Assign Ronin to Guard $ABBV 24/7
3x/Day Shift Briefs & 24/7 Stop-Loss Sentinel
+ GUARD
Locked 1-Month AI Target:$326.84 (+14.2%)Unlock Free →
Open Interactive $ABBV Chart & Ask @Saku
Institutional Quantitative & Fundamental Telemetry

$ABBV (AbbVie Inc.) Live Key Levels, RSI & Valuation Matrix

Updated Nov 22, 2026
$ABBV Technical MetricLive Value$ABBV Fundamental / Regime MetricLive Status
Live Spot Price (24h Change)$286.20 (+0.94%)Market Capitalization$505.75B
30-Day Mechanical Support Floor (Put Wall)$272.70 (4.72% cushion)52-Week High / Low Range$190.75 – $302.93
20-Day Simple Moving Average (20D SMA)$290.44Trailing P/E Ratio & Dividend Yield48.90x • Yield: 2.42%
10-Day Exponential Moving Average (10D EMA)$290.00Average Daily Volume (Liquidity)6.19M shares
30-Day Resistance Ceiling (Call Wall)$295.03 (3.09% upside to test)Next Scheduled Earnings / Catalyst Window2026-10-30
14-Day Relative Strength Index (RSI)NEUTRAL CONSOLIDATION (46.7)Saku Momentum Pulse & Health Rating64/100 Momentum • 74/100 Health
Want live sub-second candlesticks, 20D SMA / 50D EMA overlays, and real-time Support & Resistance alerts on $ABBV?Launch Interactive $ABBV Chart
Saku AI Bull vs. Bear Breakdown

Should You Buy $ABBV Stock Now or Wait?

$ABBV Bull CaseUPSIDE DRIVERS

Value and mean-reversion buyers in AbbVie Inc. ($ABBV) are monitoring the $272.70 30-day mechanical support floor (spot price at $286.20 sits 4.72% above support with 14-day RSI at 46.7 (NEUTRAL CONSOLIDATION (46.7))). Reclaiming the 10-day EMA ($290.00) and 20-day SMA pivot ($290.44) is the primary technical trigger to ignite a move back toward the $295.03 resistance ceiling.

Momentum Pulse: 64/100 (BULLISH FLOW)Predict Bull Target
$ABBV Bear Case & RisksRISK FACTORS

$ABBV (AbbVie Inc.) is currently trading below its 20-day simple moving average ($290.44) after a +2.43% 30-day move. If buyers fail to defend the 30-day mechanical support floor at $272.70 (4.72% above current spot), negative dealer gamma hedging can accelerate downside discovery toward the lower end of its 52-week range ($190.75).

Fundamental Health: 74/100 ScoreAudit Downside Risk
Technicals, Volume & Catalysts

$ABBV Support & Resistance, Institutional Flow & Catalysts.

Key Price Zones

$ABBV Support & Resistance

Spot Price: $286.20 | 30-Day Support Floor: $272.70 (4.72% above) | 10-Day EMA: $290.00 | 20-Day SMA Pivot: $290.44 | 30-Day Resistance Ceiling: $295.03 (3.09% below) | 14-Day RSI: 46.7 (NEUTRAL CONSOLIDATION (46.7)) | 30-Day Trading Corridor: 8.19% span.

Chart IndicatorsSMA • EMA • RSI
Volume & Options Activity

$ABBV Institutional & Whale Flow

Institutional order flow for $ABBV (averaging 6.19M shares daily volume) is concentrated between the $272.70 Put Wall support zone and $295.03 Call Wall resistance ceiling, with a live Saku Fundamental Health score of 74/100.

Saku Pro Deep-DiveTRACKED
Upcoming Events

$ABBV Catalyst Outlook

Next scheduled earnings window for AbbVie Inc. ($ABBV): 2026-10-30. Latest tracked headline from 247wallst.com: "$500,000 in AbbVie and Gilead Could Pay More Than $11,000 a Year in Dividends".

Asset & Corporate Profile

About AbbVie Inc. ($ABBV)

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio.

Saku's quantitative engine continuously monitors $ABBV's 30-day mechanical support floor ($272.70), 20-day simple moving average ($290.44), and 30-day resistance ceiling ($295.03) alongside off-exchange dark pool block prints and SEC filings.

Market Cap$505.75B
5-Day Velocity-2.99%
52-Week Range$190.75 – $302.93
Avg Daily Vol6.19M shares
Inspect Full $ABBV Fundamentals in Terminal
3D Agent Sanctuary • Workstation #4🔥 Early Adopter Lock-In (First 500 Desks)🎁 Code LINKEDIN: 30 Days Pro Free

Hatch Your Own 24/7 AI Co-Pilot to Guard $ABBV.

Step inside the 3D Quant Sanctuary and claim Workstation #4 to hatch your personal AI analyst (Momentum, Dip-Buyer, or Value & Catalyst style). Your agent monitors $ABBV 24/7 with locked 1-month price targets, hard stop-loss tripwires, 3x/day shift briefings, and live Koi Bridge debates.

Unlock all 4 Autonomous Quant Agents & 24/7 Stop-Loss Guard:$29/mo$14.99/mo(or $8.33/mo annual • Early Adopter Rate + 30 Days Free w/ code LINKEDIN)
app.sakustocks.com • Live $ABBV Terminal & Agent Sanctuary
Launch Full Terminal
Saku Institutional AI Terminal analyzing $ABBV (AbbVie Inc.)
“Ask @Saku or Ronin: Would you buy $ABBV right now or wait for a pullback?”
5 Guard Slots • 50 Daily @Saku Queries
Frequently Asked Questions About $ABBV

What are the live 30-day support and resistance levels for $ABBV (AbbVie Inc.)?

Spot Price: $286.20 | 30-Day Support Floor: $272.70 (4.72% above) | 10-Day EMA: $290.00 | 20-Day SMA Pivot: $290.44 | 30-Day Resistance Ceiling: $295.03 (3.09% below) | 14-Day RSI: 46.7 (NEUTRAL CONSOLIDATION (46.7)) | 30-Day Trading Corridor: 8.19% span. $ABBV currently registers a Saku Momentum Pulse score of 64/100 and a Fundamental Health score of 74/100.

Why is $ABBV (AbbVie Inc.) moving and what is the bull vs. bear thesis?

Bull Thesis: Value and mean-reversion buyers in AbbVie Inc. ($ABBV) are monitoring the $272.70 30-day mechanical support floor (spot price at $286.20 sits 4.72% above support with 14-day RSI at 46.7 (NEUTRAL CONSOLIDATION (46.7))). Reclaiming the 10-day EMA ($290.00) and 20-day SMA pivot ($290.44) is the primary technical trigger to ignite a move back toward the $295.03 resistance ceiling. Bear Thesis: $ABBV (AbbVie Inc.) is currently trading below its 20-day simple moving average ($290.44) after a +2.43% 30-day move. If buyers fail to defend the 30-day mechanical support floor at $272.70 (4.72% above current spot), negative dealer gamma hedging can accelerate downside discovery toward the lower end of its 52-week range ($190.75).

What are $ABBV's key fundamentals, 52-week range, and upcoming catalysts?

AbbVie Inc. ($ABBV) trades with a market cap of $505.75B, a P/E ratio of 48.90x, and a 52-week range of $190.75 to $302.93. Next scheduled earnings window for AbbVie Inc. ($ABBV): 2026-10-30. Latest tracked headline from 247wallst.com: "$500,000 in AbbVie and Gilead Could Pay More Than $11,000 a Year in Dividends".

Saku Tracked Assets

Explore More AI Stock & Crypto Quant Dossiers

View 14-Day Catalyst Calendar →

© 2026 Saku Financial Inc. Saku™ is a trademark of Saku Financial Inc.